Mohammed Kanaan is an Oncology physician affiliated with Troutlodge. OpenAlex indexes 24 publications with 222 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2940 S Meridian Ste 200
Puyallup, WA 983731659
Telephone
253-428-8700Provider last certified this registry record 14 Jun 2021.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20256 payments
- Tempus AI, IncProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
64.3%Other antiemetics55.4%Fosaprepitant100%Part B, office-administered≥18 patientsSerotonin-3 Receptor Antagonist7.3%Palonosetron hcl66%Ondansetron hydrochloride31%Ondansetron Odt3%Part D + Part B<11 patients+ 3 more classes in this area
Anti-infectives
16.3%Human Immunoglobulin G16.3%Immune globulin100%Part B, office-administered≥11 patientsSensory organs
9.3%Corticosteroid9.3%Dexamethasone sodium phosphate100%Part B, office-administered≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)
Journal of Drug Assessment
2018 - ”Mitt utseende och mitt namn gör det omöjligt för mig att få jobb” : En kvalitativ studie om hur unga män med invandrarbakgrund blir bemötta på arbetsmarknaden2018
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”